Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease

20011,083 citationsJournal Article

Authors

William M. Crist · Children's Oncology Group

James R. Anderson · Children's Oncology Group

Jane L. Meza · Children's Oncology Group

Christopher Fryer · Children's Oncology Group

R. Beverly Raney · Children's Oncology Group

Frederick B. Ruymann · Children's Oncology Group

John C. Breneman

Abstract

VAC and VAI or VIE with surgery (with or without RT), are equally effective for patients with local or regional rhabdomyosarcoma and are more effective for embryonal tumors than therapies used previously. Younger patients with group 1 paratesticular embryonal tumors and all patients with group 1/2 orbit or eyelid tumors can usually be cured with VA chemotherapy along with postoperative RT for group 2 disease.

Topics & Keywords

Sarcoma Diagnosis and Treatment Testicular diseases and treatments Renal and related cancers

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 19, Issue 12, pp. 3091-3102

DOI: 10.1200/jco.2001.19.12.3091

Field-Weighted Citation Impact: 24.35